Tenet Healthcare Past Earnings Performance
Past criteria checks 4/6
Tenet Healthcare has been growing earnings at an average annual rate of 56.7%, while the Healthcare industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 3.3% per year. Tenet Healthcare's return on equity is 48.9%, and it has net margins of 14.9%.
Key information
56.7%
Earnings growth rate
58.2%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 3.3% |
| Return on equity | 48.9% |
| Net Margin | 14.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Tenet Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 20,972 | 3,126 | 418 | 0 |
| 30 Jun 24 | 20,916 | 2,755 | 415 | 0 |
| 31 Mar 24 | 20,895 | 2,619 | 422 | 0 |
| 31 Dec 23 | 20,548 | 611 | 418 | 0 |
| 30 Sep 23 | 20,159 | 469 | 412 | 0 |
| 30 Jun 23 | 19,894 | 499 | 308 | 0 |
| 31 Mar 23 | 19,453 | 414 | 209 | 0 |
| 31 Dec 22 | 19,174 | 410 | 412 | 0 |
| 30 Sep 22 | 19,040 | 558 | 119 | 0 |
| 30 Jun 22 | 19,133 | 875 | 214 | 0 |
| 31 Mar 22 | 19,449 | 957 | 405 | 0 |
| 31 Dec 21 | 19,485 | 915 | 412 | 0 |
| 30 Sep 21 | 19,544 | 1,079 | 432 | 0 |
| 30 Jun 21 | 19,207 | 434 | 425 | 0 |
| 31 Mar 21 | 17,901 | 402 | 419 | 0 |
| 31 Dec 20 | 17,640 | 399 | 403 | 0 |
| 30 Sep 20 | 17,531 | -18 | 358 | 0 |
| 30 Jun 20 | 17,542 | -48 | 355 | 0 |
| 31 Mar 20 | 18,454 | -112 | 353 | 0 |
| 31 Dec 19 | 18,479 | -226 | 344 | 0 |
| 30 Sep 19 | 18,292 | -228 | 330 | 0 |
| 30 Jun 19 | 18,213 | -10 | 325 | 0 |
| 31 Mar 19 | 18,159 | -10 | 318 | 0 |
| 31 Dec 18 | 18,313 | 101 | 0 | 0 |
| 30 Sep 18 | 18,672 | -117 | 324 | 0 |
| 30 Jun 18 | 18,769 | -474 | 324 | 0 |
| 31 Mar 18 | 19,065 | -554 | 320 | 0 |
| 31 Dec 17 | 19,179 | -704 | 0 | 0 |
| 30 Sep 17 | 19,061 | -553 | 316 | 0 |
| 30 Jun 17 | 19,324 | -196 | 308 | 0 |
| 31 Mar 17 | 19,390 | -184 | 318 | 0 |
| 31 Dec 16 | 19,621 | -187 | 315 | 0 |
| 30 Sep 16 | 19,787 | -208 | 328 | 0 |
| 30 Jun 16 | 19,630 | -227 | 322 | 0 |
| 31 Mar 16 | 19,254 | -243 | 289 | 0 |
| 31 Dec 15 | 18,634 | -142 | 248 | 0 |
| 30 Sep 15 | 18,073 | 19 | 247 | 0 |
| 30 Jun 15 | 17,556 | 57 | 239 | 0 |
| 31 Mar 15 | 17,101 | 107 | 306 | 0 |
| 31 Dec 14 | 16,603 | 34 | 234 | 0 |
| 30 Sep 14 | 16,023 | -44 | 232 | 0 |
| 30 Jun 14 | 14,256 | -21 | 218 | 0 |
| 31 Mar 14 | 12,641 | -64 | 144 | 0 |
| 31 Dec 13 | 11,087 | -123 | 186 | 0 |
Quality Earnings: THC * has a large one-off gain of $2.4B impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: THC *'s current net profit margins (14.9%) are higher than last year (2.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: THC * has become profitable over the past 5 years, growing earnings by 56.7% per year.
Accelerating Growth: THC *'s earnings growth over the past year (566.5%) exceeds its 5-year average (56.7% per year).
Earnings vs Industry: THC * earnings growth over the past year (566.5%) exceeded the Healthcare industry 17.9%.
Return on Equity
High ROE: Whilst THC *'s Return on Equity (48.89%) is outstanding, this metric is skewed due to their high level of debt.